Bio

Gordon Ryerson has over 20 years of investment banking and strategic consulting experience across the pharmaceutical, medical device and pharma services industries. After co-founding Crosstree Capital Partners, Ryerson was Managing Director for Novumed Life Sciences (later acquired by E&Y Europe) leading the Global Strategic Advisory practice for pharmaceutical and medtech in- and out-licensing strategies. Ryerson has worked in the Life Sciences industry for more than 25 years, previously at OccamMD, William R. Hough & Co., and the Eckerd Drug Corporation. Ryerson holds a BS in Economics from Auburn University and a MBA from the University of South Florida.